A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2

Clinical trial NCT03847909 · COMPLETED

Trial details

NCT number: NCT03847909
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Hyperoxaluria Type 1 (PH1)Primary Hyperoxaluria Type 2 (PH2)Kidney Diseases Urologic Diseases Genetic Disease

Start date: 2019-10-28
Primary completion: 2021-06-21
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.